Evidence map›Paper›PMID 15990872›Full record

ArticleThe EMBO journal2005

Bcl-2 regulator FKBP38 is activated by Ca2+/calmodulin.

Frank Edlich, Matthias Weiwad, Frank Erdmann, Jörg Fanghänel, Franziska Jarczowski, Jens-Ulrich Rahfeld, Gunter Fischer

Abstract read
In one paragraph

Article in The EMBO journal, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. AssessingPharmaceutics · 2023
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Mitophagy Receptors in Tumor Biology.Frontiers in cell and developmental biology · 2020
    Review
  12. Functional Analysis of Peptidyl-prolylInternational journal of molecular sciences · 2019
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Journal of cell signaling · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Frank EdlichMax-Planck Research Unit for Enzymology of Protein Folding, Halle/Saale, Germany.
Matthias Weiwad
Frank Erdmann
Jörg Fanghänel
Franziska Jarczowski
Jens-Ulrich Rahfeld
Gunter Fischer

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

FKBP-type peptidyl prolyl cis/trans isomerases (PPIases) are folding helper enzymes involved in the control of functional regrowth of damaged sciatic, cortical cholinergic, dopaminergic and 5-HT neurones. Here, we show that the constitutively inactive human FK506-binding protein 38 (FKBP38) is capable of responding directly to intracellular Ca2+ rise through formation of a heterodimeric Ca2+/calmodulin/FKBP38 complex. Only complex formation creates an enzymatically active FKBP, displaying affinity for Bcl-2 mediated through the PPIase site. Association between Bcl-2 and the active site of Ca2+/calmodulin/FKBP38 regulates Bcl-2 function and thereby participates in the promotion of apoptosis in neuronal tissues. FKBP38 proapoptotic function mediated by this interaction is abolished by either potent inhibitors of the PPIase activity of the Ca2+/calmodulin/FKBP38 complex or RNA interference-mediated depletion of FKBP38, promoting neuronal cell survival.

Indexed as

ApoptosisBinding SitesCalciumCalmodulinCell Line, TumorCircular DichroismHumansPeptidylprolyl IsomeraseProto-Oncogene Proteins c-bcl-2Tacrolimus Binding ProteinsCalciumCalmodulinFKBP8 protein, humanPeptidylprolyl IsomeraseProto-Oncogene Proteins c-bcl-2Tacrolimus Binding Proteins

Identifiers

PMID15990872
PMCPMC1176465

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.